Avci, A. Et Al. 2019. Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?. POSTEPY DERMATOLOGII I ALERGOLOGII , vol.36, no.1 , 92-97.

Avci, A., Avci, D., Ertasl, R., Atasoy, M., Karakukcu, Ç., Yontar, E., ... Ulas, Y.(2019). Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?. POSTEPY DERMATOLOGII I ALERGOLOGII , vol.36, no.1, 92-97.

Avci, Atil Et Al. "Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?," POSTEPY DERMATOLOGII I ALERGOLOGII , vol.36, no.1, 92-97, 2019

Avci, Atil Et Al. "Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?." POSTEPY DERMATOLOGII I ALERGOLOGII , vol.36, no.1, pp.92-97, 2019

Avci, A. Et Al. (2019) . "Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?." POSTEPY DERMATOLOGII I ALERGOLOGII , vol.36, no.1, pp.92-97.

@article{article, author={Atil Avci Et Al. }, title={Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?}, journal={POSTEPY DERMATOLOGII I ALERGOLOGII}, year=2019, pages={92-97} }